Prof. Dr. med. Pietro Vernazza
Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study
Young J, Battegay M, Vernazza P, Tarr P, Hirschel B, Bernasconi E, Furrer H, Rickenbach M, Weber R, Bucher H. Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study. Antiviral therapy 2005; 10:585-91.
Jan 1, 2005Lipid profiles for antiretroviral-naive patients starting PI- and NNRTI-based therapy in the Swiss HIV cohort study
Jan 1, 2005Antiviral therapy 2005; 10:585-91
Young Jim, Battegay Manuel, Vernazza Pietro, Tarr Philip E, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Weber Rainer, Bucher Heiner C
HIV in semen: still more to be learned
Vernazza P. HIV in semen: still more to be learned. AIDS research and therapy 2005; 2:11.
Jan 1, 2005HIV in semen: still more to be learned
Jan 1, 2005AIDS research and therapy 2005; 2:11
Vernazza Pietro
Starting or changing therapy - a prospective study exploring antiretroviral decision-making
Fehr J, Spirig R, Jäger H, Vernazza P, Bregenzer T, Kiss A, Wagels T, Wolf E, Sendi P, Nicca D, Battegay M. Starting or changing therapy - a prospective study exploring antiretroviral decision-making. Infection 2005; 33:249-256.
Jan 1, 2005Starting or changing therapy - a prospective study exploring antiretroviral decision-making
Jan 1, 2005Infection 2005; 33:249-256
Fehr Jan, Spirig R, Jäger H, Vernazza Pietro, Bregenzer T, Kiss A, Wagels T, Wolf E, Sendi P, Nicca Dunja, Battegay Manuel
Predictive value of adherence in patients starting highly active antiretroviral treatment for HIV infection
Wagels T, Amiet R, Battegay M, Guex A, Opravil M, Vernazza P, Swiss HIV Cohort Study Group. Predictive value of adherence in patients starting highly active antiretroviral treatment for HIV infection. Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2004; 134:678-80.
Nov 13, 2004Predictive value of adherence in patients starting highly active antiretroviral treatment for HIV infection
Nov 13, 2004Swiss medical weekly : official journal of the Swiss Society of Infectious Diseases, the Swiss Society of Internal Medicine, the Swiss Society of Pneumology 2004; 134:678-80
Wagels T, Amiet R, Battegay M, Guex A C, Opravil M, Vernazza Pietro, Swiss HIV Cohort Study Group
Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine
Opravil M, Perrin L, Ledergerber B, Vernazza P, Blasko M, Bernasconi E, Calmy A, Furrer H, Chave J, Baumann D, Swiss HIV Cohort Study. Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine. AIDS (London, England) 2004; 18:2213-5.
Nov 5, 2004Long-term efficacy after switch from protease inhibitor-containing highly active antiretroviral therapy to abacavir, lamivudine, and zidovudine
Nov 5, 2004AIDS (London, England) 2004; 18:2213-5
Opravil Milos, Perrin Luc, Ledergerber Bruno, Vernazza Pietro, Blasko Monika, Bernasconi Enos, Calmy Alexandra, Furrer Hansjakob, Chave Jean-Philippe, Baumann Doris, Swiss HIV Cohort Study
[Adherence and resistance]
Klimkait T, Vernazza P. [Adherence and resistance]. Therapeutische Umschau. Revue thérapeutique 2004; 61:631-4.
Oct 1, 2004[Adherence and resistance]
Oct 1, 2004Therapeutische Umschau. Revue thérapeutique 2004; 61:631-4
Klimkait T, Vernazza Pietro
[The Swiss HIV Cohort Study: from research to health care]
Vernazza P. [The Swiss HIV Cohort Study: from research to health care]. Therapeutische Umschau. Revue thérapeutique 2004; 61:591-2.
Oct 1, 2004[The Swiss HIV Cohort Study: from research to health care]
Oct 1, 2004Therapeutische Umschau. Revue thérapeutique 2004; 61:591-2
Vernazza Pietro
Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point
Trkola A, Günthard H, Bonhoeffer S, Hirschel B, Weber R, Bernasconi E, Vernazza P, Battegay M, Furrer H, Fagard C, Oxenius A, Leemann C, Kuster H, Swiss HIV Cohort Study. Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point. Blood 2004; 104:1784-92.
Sep 15, 2004Humoral immunity to HIV-1: kinetics of antibody responses in chronic infection reflects capacity of immune system to improve viral set point
Sep 15, 2004Blood 2004; 104:1784-92
Trkola Alexandra, Günthard Huldrych F, Bonhoeffer Sebastian, Hirschel Bernard, Weber Rainer, Bernasconi Enos, Vernazza Pietro, Battegay Manuel, Furrer Hansjakob, Fagard Catherine, Oxenius Annette, Leemann Christine, Kuster Herbert, Swiss HIV Cohort Study
Is unsafe sexual behaviour increasing among HIV-infected individuals?
Glass T, Bucher H, Battegay M, Hirschel B, Cavassini M, Weber R, Rickenbach M, Vernazza P, Young J, Swiss HIV Cohort Study. Is unsafe sexual behaviour increasing among HIV-infected individuals?. AIDS (London, England) 2004; 18:1707-14.
Aug 20, 2004Is unsafe sexual behaviour increasing among HIV-infected individuals?
Aug 20, 2004AIDS (London, England) 2004; 18:1707-14
Glass Tracy R, Bucher Heiner C, Battegay Manuel, Hirschel Bernard, Cavassini Matthias, Weber Rainer, Rickenbach Martin, Vernazza Pietro, Young Jim, Swiss HIV Cohort Study
Infrequent transmission of HIV-1 drug-resistant variants
Yerly S, Perrin L, Hirschel B, Perneger T, Bernard M, Gebhardt M, Rickenbach M, Bürgisser P, Chanzy B, Furrer H, Battegay M, Vernazza P, Chave J, Kaiser L, Flepp M, Telenti A, Jost S, Swiss HIV Cohort Study. Infrequent transmission of HIV-1 drug-resistant variants. Antiviral therapy 2004; 9:375-84.
Jun 1, 2004Infrequent transmission of HIV-1 drug-resistant variants
Jun 1, 2004Antiviral therapy 2004; 9:375-84
Yerly Sabine, Perrin Luc, Hirschel Bernard, Perneger Thomas, Bernard Marie-Charlotte, Gebhardt Martin, Rickenbach Martin, Bürgisser Philippe, Chanzy Bruno, Furrer Hansjakob, Battegay Manuel, Vernazza Pietro, Chave Jean-Philippe, Kaiser Laurent, Flepp Markus, Telenti Amalio, Jost Stéphanie, Swiss HIV Cohort Study
Brief but efficient: acute HIV infection and the sexual transmission of HIV
Pilcher C, Quest Study, Cohen M, Goh L, Stewart P, Leu S, Vernazza P, Eron J, Tien H, Duke-UNC-Emory Acute HIV Consortium. Brief but efficient: acute HIV infection and the sexual transmission of HIV. The Journal of infectious diseases 2004; 189:1785-92.
May 15, 2004Brief but efficient: acute HIV infection and the sexual transmission of HIV
May 15, 2004The Journal of infectious diseases 2004; 189:1785-92
Pilcher Christopher D, Quest Study, Cohen Myron S, Goh Li-Ean, Stewart Paul W, Leu Szu-Yun, Vernazza Pietro, Eron Joseph J, Tien Hsiao Chuan, Duke-UNC-Emory Acute HIV Consortium
Sexual risk behavior in HIV-infected injection drug users
Battegay M, Bucher H, Vernazza P. Sexual risk behavior in HIV-infected injection drug users. Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004; 38:1175-7.
Apr 15, 2004Sexual risk behavior in HIV-infected injection drug users
Apr 15, 2004Clinical infectious diseases : an official publication of the Infectious Diseases Society of America 2004; 38:1175-7
Battegay Manuel, Bucher Heiner C, Vernazza Pietro
Ritonavir boosted indinavir treatment as a simplified maintenance "mono"-therapy for HIV infection
Kahlert C, Hupfer M, Wagels T, Büche D, Fierz W, Walker U, Vernazza P. Ritonavir boosted indinavir treatment as a simplified maintenance "mono"-therapy for HIV infection. AIDS (London, England) 2004; 18:955-7.
Apr 9, 2004Ritonavir boosted indinavir treatment as a simplified maintenance "mono"-therapy for HIV infection
Apr 9, 2004AIDS (London, England) 2004; 18:955-7
Kahlert Christian, Hupfer Maria, Wagels Thomas, Büche Daniel, Fierz Walter, Walker Ulrich A, Vernazza Pietro
Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection
Kaufmann G, Battegay M, Hirschel B, Rickenbach M, Bernasconi E, Vernazza P, Ledergerber B, Cavassini M, Furrer H, Perrin L, Weber R, Khanna N, Swiss HIV Cohort Study. Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection. Antiviral therapy 2004; 9:263-74.
Apr 1, 2004Long-term virological response to multiple sequential regimens of highly active antiretroviral therapy for HIV infection
Apr 1, 2004Antiviral therapy 2004; 9:263-74
Kaufmann Gilbert R, Battegay Manuel, Hirschel Bernard, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Ledergerber Bruno, Cavassini Matthias, Furrer Hansjakob, Perrin Luc, Weber Rainer, Khanna Nina, Swiss HIV Cohort Study
Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
Young J, Bucher H, Battegay M, Vernazza P, Telenti A, Hirschel B, Bernasconi E, Furrer H, Rickenbach M, Flepp M, Spirig R, De Geest S, Swiss HIV Cohort Study Group. Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study. BMJ (Clinical research ed.) 2004; 328:15.
Jan 3, 2004Stable partnership and progression to AIDS or death in HIV infected patients receiving highly active antiretroviral therapy: Swiss HIV cohort study
Jan 3, 2004BMJ (Clinical research ed.) 2004; 328:15
Young Jim, Bucher Heiner C, Battegay Manuel, Vernazza Pietro, Telenti Amalio, Hirschel Bernard, Bernasconi Enos, Furrer Hansjakob, Rickenbach Martin, Flepp Markus, Spirig Rebecca, De Geest Sabina, Swiss HIV Cohort Study Group
Ritonavir boosted Indinavir treatment as a simplified maintance „mono“-therapy for HIV infection
Kahlert C, Hupfer M, Wagels T, Büche D, Fierz W, Walker U, Vernazza P. Ritonavir boosted Indinavir treatment as a simplified maintance „mono“-therapy for HIV infection. AIDS 2004:955-957.
Jan 1, 2004Ritonavir boosted Indinavir treatment as a simplified maintance „mono“-therapy for HIV infection
Jan 1, 2004AIDS 2004:955-957
Kahlert Christian, Hupfer M, Wagels Th, Büche Daniel, Fierz W, Walker U, Vernazza Pietro
Diagnostik der latenten Tuberkulose im neuen Millenium
Hoffmann M, Vernazza P, Fierz W. Diagnostik der latenten Tuberkulose im neuen Millenium. Swiss Med Forum 2003; 3:1244-1247.
Dec 10, 2003Diagnostik der latenten Tuberkulose im neuen Millenium
Dec 10, 2003Swiss Med Forum 2003; 3:1244-1247
Hoffmann Matthias, Vernazza Pietro, Fierz Walter
Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial
Ananworanich J, Ebnöther C, Fagard C, Genné D, Khanna N, Perrin L, Phanupak P, Ubolyam S, Vernazza P, Yerly S, Cavassini M, Bernasconi E, Nüesch R, Le Braz M, Chetchotisakd P, Vibhagool A, Wicharuk S, Ruxrungtham K, Furrer H, Cooper D, Hirschel B, Swiss HIV Cohort Study. Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial. AIDS (London, England) 2003; 17:F33-7.
Oct 17, 2003Failures of 1 week on, 1 week off antiretroviral therapies in a randomized trial
Oct 17, 2003AIDS (London, England) 2003; 17:F33-7
Ananworanich Jintanat, Ebnöther C, Fagard C, Genné D, Khanna N, Perrin L, Phanupak P, Ubolyam S, Vernazza Pietro, Yerly S, Cavassini M, Bernasconi E, Nüesch Reto, Le Braz Michelle, Chetchotisakd Ploechan, Vibhagool Asda, Wicharuk Saijai, Ruxrungtham Kiat, Furrer Hansjakob, Cooper David, Hirschel Bernard, Swiss HIV Cohort Study
CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
Kaufmann G, Battegay M, Egger M, Rickenbach M, Bernasconi E, Vernazza P, Ledergerber B, Hirschel B, Telenti A, Furrer H, Opravil M, Pantaleo G, Perrin L, Swiss HIV Cohort Study Group. CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study. Archives of internal medicine 2003; 163:2187-95.
Oct 13, 2003CD4 T-lymphocyte recovery in individuals with advanced HIV-1 infection receiving potent antiretroviral therapy for 4 years: the Swiss HIV Cohort Study
Oct 13, 2003Archives of internal medicine 2003; 163:2187-95
Kaufmann Gilbert R, Battegay Manuel, Egger Matthias, Rickenbach Martin, Bernasconi Enos, Vernazza Pietro, Ledergerber Bruno, Hirschel Bernard, Telenti Amalio, Furrer Hansjakob, Opravil Milos, Pantaleo Guiseppe, Perrin Luc, Swiss HIV Cohort Study Group
Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population
Jaggy C, Hirschel B, Bernasconi E, Vernazza P, Flepp M, Battegay M, Telenti A, Furrer H, Rickenbach M, Egger M, Schwarz C, Ledergerber B, von Overbeck J, Swiss HIV Cohort Study. Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population. Lancet 2003; 362:877-8.
Sep 13, 2003Mortality in the Swiss HIV Cohort Study (SHCS) and the Swiss general population
Sep 13, 2003Lancet 2003; 362:877-8
Jaggy Christian, Hirschel Bernard, Bernasconi Enos, Vernazza Pietro, Flepp Markus, Battegay Manuel, Telenti Amalio, Furrer Hans-Jakob, Rickenbach Martin, Egger Matthias, Schwarz Claude, Ledergerber Bruno, von Overbeck Jan, Swiss HIV Cohort Study